GeneFerm Biotechnology Co., Ltd. (1796.TWO)

TWD 45.7

(-1.72%)

Eps Summary of GeneFerm Biotechnology Co., Ltd.

  • GeneFerm Biotechnology Co., Ltd.'s latest annual eps in 2023 was 3.01 TWD , up 33.19% from previous year.
  • GeneFerm Biotechnology Co., Ltd.'s latest quarterly eps in 2024 Q2 was -0.15 TWD , up 25.0% from previous quarter.
  • GeneFerm Biotechnology Co., Ltd. reported an annual eps of 2.26 TWD in 2022, up 55.86% from previous year.
  • GeneFerm Biotechnology Co., Ltd. reported an annual eps of 1.45 TWD in 2021, up 806.25% from previous year.
  • GeneFerm Biotechnology Co., Ltd. reported a quarterly eps of -0.15 TWD for 2024 Q2, up 25.0% from previous quarter.
  • GeneFerm Biotechnology Co., Ltd. reported a quarterly eps of 1.13 TWD for 2023 Q2, up 54.79% from previous quarter.

Annual Eps Chart of GeneFerm Biotechnology Co., Ltd. (2023 - 2019)

Created with Highcharts 11.1.0YearsEPS20192019.252019.52019.7520202020.252020.52020.7520212021.252021.52021.7520222022.252022.52022.752023-2 TWD-1 TWD0 TWD1 TWD2 TWD3 TWD4 TWD

Historical Annual Eps of GeneFerm Biotechnology Co., Ltd. (2023 - 2019)

Year Eps Eps Growth
2023 3.01 TWD 33.19%
2022 2.26 TWD 55.86%
2021 1.45 TWD 806.25%
2020 0.16 TWD 116.16%
2019 -0.99 TWD 0.0%

Peer Eps Comparison of GeneFerm Biotechnology Co., Ltd.